Brand Intelligence Graph
Company Overview
About Cornerstone Robotics
Cornerstone Robotics is a surgical robotics company whose Sentire Endoscopic Surgical System uses multiple robotic arms to enable minimally invasive surgery with enhanced dexterity beyond single-arm laparoscopic systems. The company raised $200 million in an oversubscribed round in November 2025, backed by the Hong Kong Investment Corporation and global sovereign wealth funds. Sentire has received China National Medical Products Administration (NMPA) approval and launched UK clinical trials for colorectal and urologic procedures in 2025, with 2026 as its international commercialization ramp year.
Business Model & Competitive Advantage
Cornerstone's multi-arm architecture is its primary technical differentiation: while Intuitive Surgical's da Vinci uses up to four arms, Sentire's design provides enhanced instrument positioning for complex minimally invasive procedures where arm geometry limits exposure. The NMPA approval gives Cornerstone immediate commercial access to the world's second-largest surgical robotics market, while the UK trial establishes the European regulatory pathway simultaneously.
Competitive Landscape 2025–2026
Sovereign wealth fund participation — rather than institutional VC — signals strategic national technology ambitions alongside financial returns. China, through the Hong Kong Investment Corporation, is actively building domestic alternatives to Intuitive Surgical's dominance in surgical robotics, and Cornerstone's NMPA approval makes it the most commercially advanced domestic competitor in this strategically important medical technology category.
Key Differentiators
Emerging Innovator
Cornerstone Robotics is an emerging player bringing innovative solutions to the MedTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Vivtex
Vivtex is an MIT Langer Laboratory spinout that has developed a drug delivery platform enabling oral administration of biologics — proteins, peptides, and other large molecules — that have historicall
Prime Medicine
Prime Medicine is a publicly-traded (Nasdaq: PRME) clinical-stage biotech developing Prime Editing — the most versatile and precise gene editing technology currently entering clinical trials, capable
Compare Cornerstone Robotics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Cornerstone Robotics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Cornerstone Robotics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Cornerstone Robotics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →